May 2013 Editor's Picks: Products from Romaco and L.B. Bohle - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

May 2013 Editor's Picks: Products from Romaco and L.B. Bohle

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Romaco
Filling machines are designed for bottling pharmaceutical liquids

Romaco extended its Macofar LF 200 product family with two models, Macofar LF 200 FD and LF 200 FS, designed for bottling pharmaceutical liquids. The LF 200 FD is used for high-speed filling of pharmaceutical sprays, nose and ear drops, ophthalmics, and syrups. The machine is equipped with two closing stations and is capable of handling a wide range of closure types including pipettes, droppers, dosing cups, spray pumps, plugs, plungers, and screw caps. The Macofar LF 200 FS is designed for applications with a single-closure system such as pump, childproof, screw, or press-on caps. It is particularly suited for processing pharmaceutical liquids that are orally administered or applied to mucous membranes. Both machines have a maximum output of 12,000 bottles per hour.

L.B. Bohle
High-efficiency dry granulator enables high-production capacity

L.B. Bohle’s BRC 100 dry granulator, now available to US markets, enables high-production capacity and minimizes material loss. An electromechanical spindle drive for the two rollers allows fast and precise control of compaction force. The BTS 200 conical Bohle Turbo Sieve eliminates what was previously a bottleneck in the process for higher throughputs. The conical sieve allows gentle particle-size reduction at low sieve speeds and is also applicable for high material throughputs. A variety of different sieve types make the BRC 100 flexible for different product and ribbon properties over a wide production range (up to 400 kg/hr, depending on the product).

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Equipment and Processing Report,
Click here